KABUL to grant regulatory approval to a Covid-19 vaccine after less than two months of human testing, a media report said on Tuesday.
The development paves the way for the mass inoculation of the Russian population, even as the final stage of clinical trials to test safety and efficacy continue.
The speed at which Russia is moving to roll out its vaccine highlights its determination to win the global race for an effective product, but has stirred concerns that it may be putting national prestige . . .
